Notably, tumor-associated macrophage-derived IL-6 binds to receptor/glycoprotein 130 (gp130) and upregulates Janus kinase (JAK)-STAT3 signaling in CRC cells, leading to increased EMT and chemoresistance, which promotes the proliferation and invasion of CRC cells [33]. This evidence concerns the gene IL6 and colorectal carcinoma.